Topics
- Jargon surrounding toxicology studies
- Early, or late stage, set backs in the registration procedure
- The importance of toxicology
- Late phase failures due to unexpected toxicity
- How packages for first into man studies are developed
- Crucial issue of acceptable safety margins
- Differences between clinical and preclinical toxicology
Who should Attend
Delegates that come into contact with toxicology data, but who are not specialist toxicologists including disciplines such as regulatory affairs, preclinical and clinical development, drug safty, project management, data management and registration.
